| Paper template |
Archives
-
LEBDA MEDICAL JOURNAL, VOL. 11, NO. 2 (30 October 2026)
Vol. 11 No. 2 (2026)We are pleased to introduce Volume 11, Number 2 (30 October 2026) of the Lebda Medical Journal, a compilation that perfectly embodies our commitment to advancing healthcare through robust, interdisciplinary research. This issue spans the full breadth of our journal's scope, bridging clinical medicine, biomedical sciences, pharmacy, and public health with a strong emphasis on localized challenges and solutions. Readers will find critical evaluations of clinical safety and laboratory biosafety compliance alongside genetic studies on cardiovascular risks and pathogen mapping in specialized care units. The volume also highlights the pharmaceutical and antimicrobial potential of native flora, while expanding into modern public health by exploring the behavioral impacts of digital media on mental well-being. Together, these contributions offer valuable insights for clinicians, researchers, and healthcare professionals dedicated to medical progress and evidence-based practice. -
LEBDA MEDICAL JOURNAL
Vol. 11 No. 1 (2026)Editorial Introduction
The April 2026 issue of Lebda Medical Journal (Vol. 11, No. 1) presents sixteen peer‑reviewed scientific papers that have undergone rigorous evaluation by expert reviewers. This issue encompasses a diverse range of topics in medicine, pharmacy, public health, and medical technology. Each article reflects the journal’s commitment to advancing scientific knowledge and promoting evidence‑based practice across health disciplines. The editorial board extends its appreciation to the authors and reviewers whose contributions have enriched this volume and strengthened the journal’s role as a platform for scholarly exchange and innovation in medical sciences
-
Lebda Medical Journal
Vol. 10 No. 2 (2025)This issue showcases a diverse and multidisciplinary collection of research articles reflecting Libya’s growing contributions to medical, pharmaceutical, and public health sciences. Topics span neurovascular insights into migraine pathophysiology, the biochemical and antibacterial properties of Libyan propolis, and pharmacist engagement in clinical practice reform. Several studies explore comparative pharmaceutical evaluations, including essential oil testing, paracetamol product analysis, and vitamin D status in Zillah municipality.
The issue also highlights strategic educational innovations such as integrating bromatology into pharmacy curricula, and investigates microbial contamination risks among health sciences students. Molecular docking studies on henna-derived compounds offer promising antimycobacterial leads, while transfusion safety is addressed through plasma quality control assessments. Finally, prescription audit data from Alkhoms city and a comprehensive review of mangosteen extract underscore the journal’s commitment to evidence-based practice and regional health priorities.
Together, these articles reflect the journal’s mission to advance scientific inquiry, clinical relevance, and public health impact across Libya and the broader region.
-
LEBDA MEDICAL JOURNAL
Vol. 9 No. 1 (2024)
